Smart Fish Omega-3 PRMs | Advanced Marine Lipids

The Clinical Advantage: Bypassing the Initial Metabolic Bottleneck

Traditional fish oils supply the body with raw EPA and DHA, relying entirely on a complex, multi-step enzymatic cascade to convert them into active downstream metabolites. Under conditions of high physical stress, metabolic exertion, or as a natural consequence of chronological aging, the initial steps of this conversion cascade frequently become highly inefficient.

Smart Fish Omega-3 PRMs are engineered to bypass this initial biological bottleneck. Rather than providing only raw fatty acids, this formula delivers 18-HEPE, 17-HDHA, and 14-HDHA—compounds identified in peer-reviewed research as critical pathway markers and direct precursors for the body's E-series resolvin, D-series resolvin, and maresin production, respectively.

Because these specialized lipid fractions sit further along the endogenous resolution pathway than raw EPA/DHA, they are positioned closer to the active mediators the body ultimately produces, avoiding the rate-limiting constraints of early-stage fatty acid metabolism.

As illustrated in the primary scientific literature above, the biosynthesis of active mediators requires successive enzymatic transformations. Smart Fish supplies the critical intermediate precursors, bypassing the initial rate-limiting breakdowns to streamline the body's natural synthesis of E-series resolvins, D-series resolvins, protectins, and maresins.